Sea Crest Wealth Management, LLC Prothena Corp Public LTD CO Transaction History

Sea Crest Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$8.85 - $12.49 $79 - $112	-9 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$8.73 - $13.74 $200 - $316	-23 Reduced 71.88%	9 $0
Q2 2018 Aug 03, 2018	SELL	$10.99 - $44.21 $538 - $2,166	-49 Reduced 60.49%	32 $0
Q1 2018 Apr 20, 2018	BUY	$27.95 - $45.04 $1,369 - $2,206	49 Added 153.13%	81 $3,000
Q4 2017 Feb 02, 2018	BUY	$35.44 - $63.76 $1,134 - $2,040	32	32 $1,000

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $678M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.